| 101 | 32457283 | Involvement of eIF2α in halofuginone-driven inhibition of TGF-β1-induced EMT. | J Biosci | 2020 |
2 |
| 102 | 32611237 | Glutamyl-Prolyl-tRNA Synthetase Regulates Proline-Rich Pro-Fibrotic Protein Synthesis During Cardiac Fibrosis. | Circ Res | 2020 Aug 28 |
4 |
| 103 | 32679143 | RETRACTED: Significance of halofuginone in esophageal squamous carcinoma cell apoptosis through HIF-1α-FOXO3a pathway. | Life Sci | 2020 Sep 15 |
2 |
| 104 | 32707492 | Halofuginone inhibits LPS-induced attachment of monocytes to HUVECs. | Int Immunopharmacol | 2020 Oct |
10 |
| 105 | 32818215 | A high throughput screen for TMPRSS2 expression identifies FDA-approved and clinically advanced compounds that can limit SARS-CoV-2 entry. | Res Sq | 2020 Aug 14 |
4 |
| 106 | 33154782 | Halofuginone inhibits tumorigenic progression of 5-FU-resistant human colorectal cancer HCT-15/FU cells by targeting miR-132-3p <i>in vitro</i>. | Oncol Lett | 2020 Dec |
1 |
| 107 | 33259259 | Halofuginone functions as a therapeutic drug for chronic periodontitis in a mouse model. | Int J Immunopathol Pharmacol | 2020 Jan-Dec |
3 |
| 108 | 33433355 | Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction. | Biomed Pharmacother | 2021 Mar |
3 |
| 109 | 33729485 | Targeting Nrf2-antioxidant signalling reverses acquired cabazitaxel resistance in prostate cancer cells. | J Biochem | 2021 Sep 22 |
3 |
| 110 | 33791697 | The Prolyl-tRNA Synthetase Inhibitor Halofuginone Inhibits SARS-CoV-2 Infection. | bioRxiv | 2021 Mar 26 |
5 |
| 111 | 33799176 | Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review. | Bioorg Chem | 2021 May |
2 |
| 112 | 34162861 | A high-throughput screen for TMPRSS2 expression identifies FDA-approved compounds that can limit SARS-CoV-2 entry. | Nat Commun | 2021 Jun 23 |
4 |
| 113 | 34209117 | Differential Effects of Halofuginone Enantiomers on Muscle Fibrosis and Histopathology in Duchenne Muscular Dystrophy. | Int J Mol Sci | 2021 Jun 30 |
1 |
| 114 | 34321315 | Nuclear Factor Erythroid 2-Related Factor 2 Depletion Sensitizes Pancreatic Cancer Cells to Gemcitabine via Aldehyde Dehydrogenase 3a1 Repression. | J Pharmacol Exp Ther | 2021 Oct |
6 |
| 115 | 34401503 | Effects of corticosteroids vs halofuginone on vocal fold wound healing in an ovine model. | Laryngoscope Investig Otolaryngol | 2021 Aug |
5 |
| 116 | 34405694 | Antifibrotic Therapy Augments the Antitumor Effects of Vesicular Stomatitis Virus Via Reprogramming Tumor Microenvironment. | Hum Gene Ther | 2022 Mar |
1 |
| 117 | 34628069 | Halofuginone enhances the anti-tumor effect of ALA-PDT by suppressing NRF2 signaling in cSCC. | Photodiagnosis Photodyn Ther | 2022 Mar |
1 |
| 118 | 34901018 | Halofuginone Sensitizes Lung Cancer Organoids to Cisplatin <i>via</i> Suppressing PI3K/AKT and MAPK Signaling Pathways. | Front Cell Dev Biol | 2021 |
2 |
| 119 | 34954499 | Inhibition of GCN2 alleviates hepatic steatosis and oxidative stress in obese mice: Involvement of NRF2 regulation. | Redox Biol | 2022 Feb |
3 |
| 120 | 35466425 | Cellular responses to halofuginone reveal a vulnerability of the GCN2 branch of the integrated stress response. | EMBO J | 2022 Jun 1 |
4 |
| 121 | 35618180 | Halofuginone micelle nanoparticles eradicate Nrf2-activated lung adenocarcinoma without systemic toxicity. | Free Radic Biol Med | 2022 Jul |
2 |
| 122 | 35636724 | Prospects of halofuginone as an antiprotozoal drug scaffold. | Drug Discov Today | 2022 May 27 |
1 |